References
- Shenoy ES, Macy E, Rowe T, et al. Evaluation and management of penicillin allergy: a review. J Am Med Assoc. 2019;321(2):188–199.
- Rodríguez-Baño J, Paño-Pardo JR, Alvarez-Rocha L, et al. Programas de optimización de uso de antimicrobianos (PROA) en hospitales españoles: documento de consenso GEIH-SEIMC, SEFH y SEMPSPH. Farm Hosp. 2012;36(1):33.e1–33.e30.
- Blumenthal KG, Lu N, Zhang Y, et al. Recorded penicillin allergy and risk of mortality: a population-based matched cohort study. J Gen Intern Med. 2019;34(9):1685–1687.
- Blumenthal KG, Lu N, Zhang Y, et al. Risk of meticillin resistant Staphylococcus aureus and Clostridium difficile in patients with a documented penicillin allergy: population based matched cohort study. Bmj. 2018;361:k2400.
- Blumenthal KG, Wickner PG, Hurwitz S, et al. Tackling inpatient penicillin allergies: assessing tools for antimicrobial stewardship. J Allergy Clin Immunol. 2017;140(1):154–161.e6.
- Rose MT, Slavin M, Trubiano J. The democratisation of de-labelling: a review of direct oral challenge in adults with low-risk penicillin allergy. Expert Rev Anti Infect Ther. 2020;18(11):1143–1153.
- Blumenthal KG, Peter JG, Trubiano JA, et al. Antibiotic allergy. Lancet. 2019;393(10167):183–198.
- Castells M, Khan DA, Phillips E. Penicillin Allergy. N Engl J Med. 2019;381(24):2338–2351.
- Trubiano JA, Franklin Adkinson N, Phillips EJ. Penicillin allergy is not necessarily forever. J Am Med Assoc. 2017;318(1):82–83.
- Estep PM, Ferreira JA, Dupree LH, et al. Impact of an antimicrobial stewardship initiative to evaluate β-lactam allergy in patients ordered aztreonam. Am J Heal Pharm. 2016;73(5_Supplement_1):S8–S13.
- Trubiano JA, Beekmann SE, Worth LJ, et al. Improving antimicrobial stewardship by antibiotic allergy delabeling: evaluation of knowledge, attitude, and practices throughout the emerging infections network. Open Forum Infect Dis. 2016;3(3):1–4.
- Unger NR, Gauthier TP, Cheung LW. Penicillin skin testing: potential implications for antimicrobial stewardship. Pharmacotherapy. 2013;33(8):856–867.
- Harmon S, Richardson T, Simons H, et al. The clinical and financial impact of a pharmacist-driven penicillin skin testing program on antimicrobial stewardship practices. Hospital Pharmacy. 2020;55(1):58–63.
- Doña I, Torres MJ, Montañez MI, et al. In vitro diagnostic testing for antibiotic allergy. Allergy, Asthma Immunol Res. 2017;9(4):288–298.
- Chen XJC, Fong K, Altshuler D, et al. Evaluation of pharmacy-developed antibiotic desensitization protocols. Ann Pharmacother. 2019;53(3):229–251.
- Gupta M, Gomes JM, Irizarry J, et al. The use of standardized drug desensitization protocols at a pediatric institution. J Allergy Clin Immunol Pract. 2017;5(3):834–836.e5.
- Habib G, Lancellotti P, Antunes MJ, et al. ESC Guidelines for the management of infective endocarditis. Eur Heart J. 2015;36(44):3075–3123.
- Chastain DB, Hutzley VJ, Parekh J, et al. Antimicrobial desensitization: a review of published protocols. Pharmacy. 2019;7(3):112.
- Jones BM, Jozefczyk C, Maguire C, et al. Beta-lactam allergy review: implications for antimicrobial stewardship programs. Curr Treat Options Infect Dis. 2019;11(2):103–114.
- Wunderink RG, Srinivasan A, Barie PS, et al. Antibiotic stewardship in the intensive care unit : an official American thoracic society workshop report in collaboration with the aacn, chest, cdc, and sccm. Ann Am Thorac Soc. 2020;17(5):531–540.
- Moher D, Liberati A, Tetzlaff J, et al. preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Ann Intern Med. 2009;151(4):264–269.
- Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
- Charlson M, Szatrowski TP, Peterson J, et al. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245–1251.
- Seymour CW, Liu ITJsVX, Iwashyna TJ, et al. Assessment of clinical criteria for sepsis for the third international consensus definitions for sepsis and septic shock (sepsis-3). J Am Med Assoc. 2016;315(8):762–774.
- CDC/NHSN. Surveillance definitions for specific type of infections. Surveill Defin. 2020;1–24.
- European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters, Version 1.3 [Internet]. 2011. Available from: http://www.eucast.org/clinical_breakpoints.
- Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281.
- Legendre DP, Muzny CA, Marshall GD, et al. Antibiotic hypersensitivity reactions and approaches to desensitization. Infect Dis (Auckl). 2013;58(8):1140–1148.
- Castells M. Rapid desensitization for hypersensitivity reactions to medications. Immunol Allergy Clin North Am. 2009;29(3):585–606.
- Yates AB. Management of patients with a history of allergy to beta-lactam antibiotics. Am J Med. 2008;121(7):572–576.
- Jeimy S, Ben-Shoshan M, Abrams EM, et al. Practical guide for evaluation and management of beta-lactam allergy: position statement from the Canadian Society of Allergy and Clinical Immunology. Allergy, Asthma Clin Immunol. 2020;16(1):1–10.
- Zagursky RJ, Pichichero ME. Cross-reactivity in β-Lactam Allergy. J Allergy Clin Immunol Pract. 2018;6(1):72–81.e1.
- González-García R, Albanell-Fernández M, Aranda L, et al. Evaluation of desensitization protocols to betalactam antibiotics. J Clin Pharm Ther. 2021;46(1):1–8.
- Trissel LA, Ashworth LD, Ashworth J. Trissel’s stability of compounded formulations. 6th (United States: Apha Publications) ed. 2018.